Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Multicentre, Double-Blinded and Placebo-Controlled, Trial of Human Albumin in the Treatment of Decompensated Cirrhosis Guided by the MICROB-PREDICT Biomarker

NCT05056220 is registered in ClinicalTrials.gov with Aleksander Krag as lead sponsor.

NCT NCT05056220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05056220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Multicentre, Double-Blinded and Placebo-Controlled, Trial of Human Albumin in the Treatment of Decompensated Cirrhosis Guided by the MICROB-PREDICT Biomarker
Lead sponsor
Aleksander Krag
Phase
Phase 3
Overall status
Recruiting
Start date
February 26, 2024
Completion date
September 30, 2026
Enrollment
240 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated cirrhosis and ascites